CCL5 and rheumatoid arthritis: In conclusion, our results from this study suggest that RANTES/CCL5 plays a role of an active mediator, not a passive bystander, in RA pathogenesis by activating RASFs to promote MMP-1 and MMP-13 mediated ECM destruction.